Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 3631-3640 of 10862

Edit search filters
  1. Wearable Technology for Health Monitoring in a Urological Patient Population.

    Rochester, MN

  2. Wearables for Assessing Nontechnical and Technical Skills

  3. Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3)

    Scottsdale/Phoenix, AZ

  4. A Study to Evaluate the Safety, Effectiveness, and Tolerability of Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrent C. Diff

    Rochester, MN

  5. A Study to Investigate the Effectiveness and Safety of Injectafer for the Treatment of Restless Legs Syndrome

    Scottsdale/Phoenix, AZ

  6. Statins and CPAP in Adipose Tissue of OSA

    Rochester, MN

  7. Atrial Fibrillation Screening and Education Study

    Rochester, MN

  8. A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)

    Rochester, MN

  9. A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naïve Adults With Chronic Hepatitis C Virus (HCV) Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. A Study to Assess Outcomes of Patients Treated with AFX System Compared to Other EVAR Devices

    Jacksonville, FL

.

Mayo Clinic Footer